OCX logo

OncoCyte (OCX) Net Income

Annual Net Income

-$27.78 M
+$45.12 M+61.89%

December 31, 2023

Summary

Performance

1-Year Change

+61.89%

3-Year Change

+7.19%

5-Year Change

-76.34%

15-Year Change

-43.39%

OCX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.43%
OCX annual net profit is higher than 51.43% of companies in Healthcare sector

High & Low

All-time High

-$3.50 M

3-Year Low

-$72.90 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
OCX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 11, 2025
OCX next annual earnings announcement is scheduled for Apr 11, 2025

OtherOCXprofitabilitymetrics:

Annual Net Margin

-1848.37%
OCX annual net profit margin is -1848.37%

Annual Revenue

$1.50 M
OCX annual revenue is $1.50 million

Annual Gross Profit

$413.00 K
OCX annual gross profit is $413.00 thousand

Annual EPS

-$3.75
OCX annual earnings per share is -$3.75

Quarterly Net Income

-$13.49 M
-$8.96 M-197.86%

September 30, 2024

Summary

Performance

3-Month Change

-197.86%

1-Year Change

-107.94%

3-Year Change

-62.57%

5-Year Change

-62.57%

OCX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

34.48%
OCX quarterly net profit is higher than 34.48% of companies in Healthcare sector

High & Low

All-time High

$3.03 M
OCX quarterly net profit is currently -544.87% below its historical high of $3.03 million

3-Year Low

-$44.98 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OCX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 11, 2025
OCX next earnings announcement is scheduled for Apr 11, 2025

OtherOCXprofitabilitymetrics:

Quarterly Net Margin

-11.73 K%
OCX quarterly net profit margin is -11.73 thousand%

Quarterly Revenue

$115.00 K
OCX quarterly revenue is $115.00 thousand

Quarterly Gross Profit

$50.00 K
OCX quarterly gross profit is $50.00 thousand

Quarterly EPS

-$0.98
OCX quarterly earnings per share is -$0.98

TTM Net Income

-$43.14 M
-$7.00 M-19.38%

September 30, 2024

Summary

Performance

3-Month Change

-19.38%

1-Year Change

+24%

3-Year Change

+36.81%

5-Year Change

+36.81%

OCX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.27%
OCX TTM net profit is higher than 40.27% of companies in Healthcare sector

High & Low

All-time High

-$1.51 M

3-Year Low

-$72.90 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
OCX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 11, 2025
OCX next earnings announcement is scheduled for Apr 11, 2025

OtherOCXprofitabilitymetrics:

Annual Net Margin

-1848.37%
OCX annual net profit margin is -1848.37%

TTM Revenue

$709.00 K
OCX TTM revenue is $709.00 thousand

TTM Gross Profit

-$115.00 K
OCX TTM gross profit is -$115.00 thousand

TTM EPS

-$4.54
OCX TTM earnings per share is -$4.54

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$27.78 M
OCX annual net profit is -$27.78 million

Annual Revenue

$1.50 M
OCX annual revenue is $1.50 million

Annual Cost Of Goods Sold

$1.09 M
OCX annual cost of goods sold is $1.09 million

Annual Operating Expenses

$22.83 M
OCX annual total operating expenses is $22.83 million

Annual Interest Expense

$52.00 K
OCX annual interest expense is $52.00 thousand

Annual Income Tax

-
OCX annual income tax value is unknown

OCX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+61.9%-107.9%+24.0%
3 y3 years+7.2%-62.6%+36.8%
5 y5 years-76.3%-62.6%+36.8%

OCX Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+61.9%-544.9%+70.0%-55.3%+40.8%
5 y5-year-23.9%+61.9%-544.9%+70.0%-92.4%+40.8%
alltimeall time-694.9%+61.9%-544.9%+70.0%-2762.9%+40.8%

OncoCyte Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$13.49 M(+197.9%)
-$43.14 M(+19.4%)
Jun 2024
-
-$4.53 M(-50.4%)
-$36.14 M(-9.5%)
Mar 2024
-
-$9.13 M(-42.9%)
-$39.94 M(+43.8%)
Dec 2023
-$27.78 M(-61.9%)
-$15.99 M(+146.4%)
-$27.78 M(-51.1%)
Sep 2023
-
-$6.49 M(-22.1%)
-$56.77 M(-4.8%)
Jun 2023
-
-$8.33 M(-374.7%)
-$59.61 M(+0.1%)
Mar 2023
-
$3.03 M(-106.7%)
-$59.58 M(-18.3%)
Dec 2022
-$72.90 M(+13.7%)
-$44.98 M(+381.9%)
-$72.90 M(+14.3%)
Sep 2022
-
-$9.33 M(+12.4%)
-$63.81 M(-6.5%)
Jun 2022
-
-$8.30 M(-19.3%)
-$68.28 M(-3.1%)
Mar 2022
-
-$10.29 M(-71.3%)
-$70.47 M(+9.9%)
Dec 2021
-$64.10 M(+114.1%)
-$35.88 M(+160.0%)
-$64.10 M(+85.7%)
Sep 2021
-
-$13.80 M(+31.5%)
-$34.52 M(+25.5%)
Jun 2021
-
-$10.49 M(+167.7%)
-$27.50 M(+5.3%)
Mar 2021
-
-$3.92 M(-37.9%)
-$26.12 M(-12.7%)
Dec 2020
-$29.93 M(+33.5%)
-$6.31 M(-7.0%)
-$29.93 M(-5.2%)
Sep 2020
-
-$6.78 M(-25.5%)
-$31.58 M(+5.2%)
Jun 2020
-
-$9.11 M(+17.8%)
-$30.02 M(+14.2%)
Mar 2020
-
-$7.73 M(-2.8%)
-$26.29 M(+17.2%)
Dec 2019
-$22.43 M
-$7.95 M(+52.2%)
-$22.43 M(+18.2%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$5.22 M(-2.9%)
-$18.97 M(+13.5%)
Jun 2019
-
-$5.38 M(+39.3%)
-$16.72 M(+5.5%)
Mar 2019
-
-$3.86 M(-14.1%)
-$15.84 M(+0.5%)
Dec 2018
-$15.75 M(-18.7%)
-$4.50 M(+51.4%)
-$15.75 M(+3.5%)
Sep 2018
-
-$2.97 M(-34.1%)
-$15.21 M(-20.5%)
Jun 2018
-
-$4.50 M(+19.2%)
-$19.15 M(+3.8%)
Mar 2018
-
-$3.78 M(-4.6%)
-$18.45 M(-4.8%)
Dec 2017
-$19.38 M(+73.5%)
-$3.96 M(-42.7%)
-$19.37 M(+4.6%)
Sep 2017
-
-$6.91 M(+81.5%)
-$18.52 M(+30.3%)
Jun 2017
-
-$3.80 M(-19.1%)
-$14.21 M(+9.7%)
Mar 2017
-
-$4.70 M(+51.6%)
-$12.95 M(+15.9%)
Dec 2016
-$11.17 M(+27.9%)
-$3.10 M(+19.6%)
-$11.17 M(-3.8%)
Sep 2016
-
-$2.60 M(+2.0%)
-$11.61 M(+1.6%)
Jun 2016
-
-$2.54 M(-13.1%)
-$11.43 M(+11.0%)
Mar 2016
-
-$2.93 M(-17.3%)
-$10.29 M(+17.8%)
Dec 2015
-$8.73 M(+75.2%)
-$3.54 M(+46.5%)
-$8.73 M(+30.3%)
Sep 2015
-
-$2.42 M(+71.2%)
-$6.70 M(+56.4%)
Jun 2015
-
-$1.41 M(+3.1%)
-$4.29 M(+49.1%)
Mar 2015
-
-$1.37 M(-9.2%)
-$2.88 M(+90.8%)
Dec 2014
-$4.99 M(+42.7%)
-$1.51 M
-$1.51 M
Dec 2013
-$3.50 M
-
-

FAQ

  • What is OncoCyte annual net profit?
  • What is the all time high annual net income for OncoCyte?
  • What is OncoCyte annual net income year-on-year change?
  • What is OncoCyte quarterly net profit?
  • What is the all time high quarterly net income for OncoCyte?
  • What is OncoCyte quarterly net income year-on-year change?
  • What is OncoCyte TTM net profit?
  • What is the all time high TTM net income for OncoCyte?
  • What is OncoCyte TTM net income year-on-year change?

What is OncoCyte annual net profit?

The current annual net income of OCX is -$27.78 M

What is the all time high annual net income for OncoCyte?

OncoCyte all-time high annual net profit is -$3.50 M

What is OncoCyte annual net income year-on-year change?

Over the past year, OCX annual net profit has changed by +$45.12 M (+61.89%)

What is OncoCyte quarterly net profit?

The current quarterly net income of OCX is -$13.49 M

What is the all time high quarterly net income for OncoCyte?

OncoCyte all-time high quarterly net profit is $3.03 M

What is OncoCyte quarterly net income year-on-year change?

Over the past year, OCX quarterly net profit has changed by -$7.00 M (-107.94%)

What is OncoCyte TTM net profit?

The current TTM net income of OCX is -$43.14 M

What is the all time high TTM net income for OncoCyte?

OncoCyte all-time high TTM net profit is -$1.51 M

What is OncoCyte TTM net income year-on-year change?

Over the past year, OCX TTM net profit has changed by +$13.62 M (+24.00%)